As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer ...

With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.

Xodus’ portfolio “complements and expands Steris’ offering, particularly by adding consumables used in the operating room,” ...

Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three ...

In a strategy shift, the company will invest in its procedural ultrasound business, supporting cardiovascular surgeries ...

MiniMed completed its separation from Medtronic, the companies said Thursday. The diabetes technology firm, which went public ...

The payments were made after a California arbitrator found private text messages between Orthofix executives couldn’t be ...

For the second straight quarter, the cardiovascular unit experienced slower sales growth due to ongoing struggles in the ...

Zimmer distributes an exclusive version of Think’s wireless handheld miniature robotic system that works with its Persona ...

Chief commercial officer, EndoQuest Robotics. Previous title: Vice president of robotics, AI and neuroscience, HCA Healthcare ...

Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.

The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts ...